Dipyridamole Induced Ischemia and Biomarkers

University of Pecs50 enrolled

Overview

Analysis of certain biomarkers and transient myocardial perfusion deficit revealed by myocardial perfusion scintigraphy.

The prospectively enrolled patients were followed up to 5 years. Adverse major events (MI, stroke, death) suffered during follow-up were retrospectively analysed.

Study Type

OBSERVATIONAL

Enrollment

Conditions

Ischemic Heart Disease Ischemic Attack

Interventions

myocardial perfusion scintigraphyDIAGNOSTIC_TEST

Myocardial perfusion scintigraphy as it is described in the international literature.

Eligibility

Sex: ALL

Medical Language ↔ Plain English

Inclusion Criteria: 1. written informed consent. 2. clinical diagnosis of ischemic heart disease (IHD) - Exclusion Criteria: 1. refused written informed consent. 2. lost data during follow-up \-

Locations (1)

University of Pecs

Pécs, Baranya, Hungary

Outcomes

Primary Outcomes

Myocardial perfusion abnormality

Myocardial perfusion was quantified based on myocardial perfusion scintigraphy (MPS).

Time frame: 5 year follow-up after MPS

Data from ClinicalTrials.gov

This platform is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare professional.